Latest & greatest articles for otitis media

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on otitis media or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on otitis media and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for otitis media

161. Cost of ciprofloxacin/dexamethasone vs amoxicillin/clavulanic acid for the treatment of acute otitis media in tympanostomy tube patients in the US

Cost of ciprofloxacin/dexamethasone vs amoxicillin/clavulanic acid for the treatment of acute otitis media in tympanostomy tube patients in the US Cost of ciprofloxacin/dexamethasone vs amoxicillin/clavulanic acid for the treatment of acute otitis media in tympanostomy tube patients in the US Cost of ciprofloxacin/dexamethasone vs amoxicillin/clavulanic acid for the treatment of acute otitis media in tympanostomy tube patients in the US Schmier J K, Waycaster C R, Wall G M Record Status (...) This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary The study compared the cost-effectiveness of ciprofloxacin-dexamethasone ear drops with oral amoxicillin-clavulanic acid for the treatment of patients with acute otitis media in the tympanostomy tube (AOMT

2007 NHS Economic Evaluation Database.

162. Cost-effectiveness analysis of treatment options for acute otitis media (Full text)

Cost-effectiveness analysis of treatment options for acute otitis media Cost-effectiveness analysis of treatment options for acute otitis media Cost-effectiveness analysis of treatment options for acute otitis media Coco A S Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability (...) of the study and the conclusions drawn. Health technology The study compared four strategies for the treatment of acute otitis media (AOM). The strategies were: watchful waiting, involving 72 hours of observation of possible symptom recession before administering amoxicillin; delayed prescription (DP), patients return to the office for a prescription of amoxicillin in the case that symptoms continue for 48 to 72 hours; routine antibiotic treatment with 5 days of amoxicillin; and routine antibiotic

2007 NHS Economic Evaluation Database. PubMed abstract

163. Review: treatment with ventilation tubes has little effect in children with otitis media with effusion (Full text)

Review: treatment with ventilation tubes has little effect in children with otitis media with effusion Review: treatment with ventilation tubes has little effect in children with otitis media with effusion | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal (...) accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Review: treatment with ventilation tubes has little effect in children with otitis media with effusion Article Text Therapeutics Review: treatment with ventilation tubes has little effect

2006 Evidence-Based Medicine PubMed abstract

164. [From the Cochrane Library: topical antibiotic treatment is more effective than systemic antibiotic treatment for chronic otitis media with eardrum perforation and purulent discharge]. (Abstract)

[From the Cochrane Library: topical antibiotic treatment is more effective than systemic antibiotic treatment for chronic otitis media with eardrum perforation and purulent discharge]. Chronic suppurative otitis media with underlying persistent eardrum perforation is a common cause of preventable hearing impairment. A Cochrane systematic review compared topical treatment (antibiotics or antiseptics) with systemic antibiotics to identify which is best. Nine randomised controlled trials were

2006 Nederlands tijdschrift voor geneeskunde

165. Antibiotics for acute otitis media: a meta-analysis with individual patient data. (Abstract)

Antibiotics for acute otitis media: a meta-analysis with individual patient data. Individual trials to test effectiveness of antibiotics in children with acute otitis media have been too small for valid subgroup analyses. We aimed to identify subgroups of children who would and would not benefit more than others from treatment with antibiotics.We did a meta-analysis of data from six randomised trials of the effects of antibiotics in children with acute otitis media. Individual patient data from (...) 1643 children aged from 6 months to 12 years were validated and re-analysed. We defined the primary outcome as an extended course of acute otitis media, consisting of pain, fever, or both at 3-7 days.Significant effect modifications were noted for otorrhoea, and for age and bilateral acute otitis media. In children younger than 2 years of age with bilateral acute otitis media, 55% of controls and 30% on antibiotics still had pain, fever, or both at 3-7 days, with a rate difference between

2006 Lancet

166. Antihistamines and/or decongestants for otitis media with effusion (OME) in children. (Abstract)

Antihistamines and/or decongestants for otitis media with effusion (OME) in children. Otitis media with effusion (OME) is common and may cause hearing loss with associated developmental delay. Treatment remains controversial. The effectiveness of antihistamines, decongestants and antihistamine/decongestant combinations in promoting the resolution of effusions has been assessed by randomized controlled trials.The objective of this review is to determine whether antihistamine, decongestant (...) searched by hand; pharmaceutical manufacturers of antihistamines and decongestants and first authors of included studies were contacted to identify other potentially relevant studies.Randomized controlled trials (RCTs) using antihistamines, decongestants or antihistamine/decongestant combinations as treatment for OME in children were selected. We excluded trials that randomized on the basis of acute otitis media (AOM) even though OME was also studied in follow up.Data were extracted from the published

2006 Cochrane database of systematic reviews (Online)

167. Antibiotics for the prevention of acute and chronic suppurative otitis media in children. (Abstract)

Antibiotics for the prevention of acute and chronic suppurative otitis media in children. Acute otitis media (AOM) is a common childhood illness. These middle ear infections may be frequent and painful. AOM may be associated with perforation of the tympanic membrane and can progress to chronic suppurative otitis media (CSOM).To determine the effectiveness of long-term antibiotics (for longer than six weeks) in preventing any AOM, AOM with perforation and CSOM.We searched the Cochrane Central (...) to otitis media. The majority of studies were high quality and most (15 studies) reported data for our primary outcomes. None reported AOM with perforation or CSOM. Long-term antibiotics reduced any episode of AOM (13 studies, 1358 children, risk ratio (RR) 0.62, 95% CI 0.52 to 0.75; random-effects model) and number of episodes of AOM (12 studies, 1112 children, incidence rate ratio (IRR) 0.48, 95% CI 0.37 to 0.62; random-effects model). Approximately five children would need to be treated long term

2006 Cochrane

168. Autoinflation for hearing loss associated with otitis media with effusion. (Abstract)

Autoinflation for hearing loss associated with otitis media with effusion. Otitis media with effusion (OME) or 'glue ear' is an accumulation of fluid in the middle ear, in the absence of acute inflammation or infection. It is the commonest cause of acquired hearing loss in childhood and the usual reason for insertion of 'grommets'. Potential treatments include decongestants, mucolytics, steroids, antihistamines and antibiotics. Autoinflation devices have been proposed as a simple mechanical (...) means of improving 'glue ear'.To determine the effects of autoinflation in adults and children with otitis media with effusion.We searched the Cochrane Ear, Nose and Throat Disorders Group Trials Register, CENTRAL (The Cochrane Library Issue 1, 2006), MEDLINE (1951 to 2006), EMBASE (1974 to 2006) and twelve other databases, using the Cochrane Ear, Nose and Throat Disorders Group search strategy.We selected randomised controlled trials that compared any form of autoinflation to no autoinflation

2006 Cochrane

169. Oral or topical nasal steroids for hearing loss associated with otitis media with effusion in children. (Abstract)

Oral or topical nasal steroids for hearing loss associated with otitis media with effusion in children. Otitis media with effusion (OME) is common and may cause hearing loss with associated developmental delay. Treatment remains controversial.To examine evidence for or against treating children with hearing loss associated with OME with systemic or topical intranasal steroids.We searched the Cochrane Ear, Nose and Throat Disorders Group Specialised Register, the Cochrane Central Register

2006 Cochrane database of systematic reviews (Online)

170. Topical analgesia for acute otitis media. (Full text)

Topical analgesia for acute otitis media. Acute otitis media (AOM) is a spontaneously remitting disease for which pain is the most distressing symptom. Antibiotics are now known to have less benefit than previously assumed.To assess the effectiveness of topical analgesia for AOM.We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library Issue 2, 2006), MEDLINE (1966 to May Week 3 2006), EMBASE (1990 to December 2005) and LILACS (1982 to September 2005

2006 Cochrane database of systematic reviews (Online) PubMed abstract

171. Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media. (Full text)

Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media. Chronic otitis media (OM) is a common pediatric infectious disease. Previous studies demonstrating that metabolically active bacteria exist in culture-negative pediatric middle-ear effusions and that experimental infection with Haemophilus influenzae in the chinchilla model of otitis media results in the formation of adherent mucosal biofilms suggest that chronic OM may result from a mucosal (...) biofilm infection.To test the hypothesis that chronic OM in humans is biofilm-related.Middle-ear mucosa (MEM) biopsy specimens were obtained from 26 children (mean age, 2.5 [range, 0.5-14] years) undergoing tympanostomy tube placement for treatment of otitis media with effusion (OME) and recurrent OM and were analyzed using microbiological culture, polymerase chain reaction (PCR)-based diagnostics, direct microscopic examination, fluorescence in situ hybridization, and immunostaining. Uninfected

2006 JAMA PubMed abstract

172. Systematic literature review of modifiable risk factors for recurrent acute otitis media in childhood. (Full text)

Systematic literature review of modifiable risk factors for recurrent acute otitis media in childhood. Review evidence about modifiable risk factors for recurrent acute otitis media.MEDLINE with no language restriction, from January 1966 to July 2005, using descriptors "acute otitis media/risk factors". Two hundred and fifty-seven articles were obtained. These included randomized clinical trials, cohorts, case-control and cross-sectional studies that contained analyses of modifiable risk (...) factors for the development of recurrent acute otitis media as the main objective and with samples of individuals up to the age of 18 years. Except when relevant, the following were excluded: non-systematic reviews, reports of cases, series of cases, and medical society guidelines.Nine risk factors linked to the host and eight linked to the environment were identified. Of the first group, allergy, craniofacial abnormalities, gastroesophageal reflux and the presence of adenoids were classified

2006 Jornal de pediatria PubMed abstract

173. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study. (Abstract)

Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study. Acute otitis media is one of the most commonly-diagnosed childhood infections. This study assessed the efficacy of a novel vaccine that contained polysaccharides from 11 different Streptococcus pneumoniae serotypes each conjugated to Haemophilus influenzae-derived protein D (...) in prevention of acute otitis media.4968 infants were randomly assigned to receive either pneumococcal protein D conjugate or hepatitis A vaccine at the ages of 3, 4, 5, and 12-15 months and were followed-up until the end of the second year of life. Middle-ear fluid was obtained for bacteriological culture and serotyping in children who presented with abnormal tympanic membrane or presence of middle-ear effusion, plus two predefined clinical symptoms. The primary endpoint was protective efficacy against

2006 Lancet Controlled trial quality: predicted high

174. Wait-and-see prescription for the treatment of acute otitis media: a randomized controlled trial. (Full text)

Wait-and-see prescription for the treatment of acute otitis media: a randomized controlled trial. Acute otitis media (AOM) is the most common diagnosis for which antibiotics are prescribed for children. Previous trials that have evaluated a "wait-and-see prescription" (WASP) for antibiotics, with which parents are asked not to fill the prescription unless the child either is not better or is worse in 48 hours, have excluded children with severe AOM. None of these trials were conducted

2006 JAMA Controlled trial quality: predicted high PubMed abstract

175. Cost-effectiveness of implementing national guidelines in the treatment of acute otitis media in children

Cost-effectiveness of implementing national guidelines in the treatment of acute otitis media in children Cost-effectiveness of implementing national guidelines in the treatment of acute otitis media in children Cost-effectiveness of implementing national guidelines in the treatment of acute otitis media in children Koskinen H, Rautakorpi U M, Sintonen H, Honkanen P, Huikko S, Huovinen P, Klaukka T, Palva E, Roine R P, Sarkkinen H, Varonen H, Makela M Record Status This is a critical abstract (...) of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The use of national guidelines in the treatment of acute otitis media (AOM) in children was investigated. These guidelines were part of a programme introducing guidelines for six common infections. The patients or the caregiver filled

2006 NHS Economic Evaluation Database.

176. Review: topical quinolones are better than systemic antibiotics for chronic suppurative otitis media at up to 2 weeks

Review: topical quinolones are better than systemic antibiotics for chronic suppurative otitis media at up to 2 weeks Review: topical quinolones are better than systemic antibiotics for chronic suppurative otitis media at up to 2 weeks | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your (...) username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Review: topical quinolones are better than systemic antibiotics for chronic suppurative otitis media at up to 2 weeks Article Text Therapeutics Review

2006 Evidence-Based Medicine

177. Review: antibiotics are moderately effective for acute otitis media in children (Full text)

Review: antibiotics are moderately effective for acute otitis media in children Review: antibiotics are moderately effective for acute otitis media in children | Evidence-Based Nursing We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional accounts (...) Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Review: antibiotics are moderately effective for acute otitis media in children Article Text Treatment Review: antibiotics are moderately effective for acute otitis media in children Free Stephanie Wright , RN, PhD, CFNP, CPNP

2005 Evidence-Based Nursing PubMed abstract

178. Review: ear pain and a cloudy, bulging, or distinctly immobile tympanic membrane appear to help diagnose acute otitis media in children (Full text)

Review: ear pain and a cloudy, bulging, or distinctly immobile tympanic membrane appear to help diagnose acute otitis media in children Review: ear pain and a cloudy, bulging, or distinctly immobile tympanic membrane appear to help diagnose acute otitis media in children | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies (...) media in children Article Text Diagnosis Review: ear pain and a cloudy, bulging, or distinctly immobile tympanic membrane appear to help diagnose acute otitis media in children Free Matti Uhari , MD, MSc Statistics from Altmetric.com Rothman R, Owens, Simel DL. Does this child have acute otitis media? JAMA 2003 ; 290 : 1633 –40. Q In children, how accurate are symptoms and signs for diagnosing acute otitis media (AOM)? Clinical impact ratings GP/FP/Primary care ★★★★☆☆☆ Emergency medicine ★★★★★

2005 Evidence-Based Medicine PubMed abstract

179. EarPopper for the treatment of otitis media with effusion in children

EarPopper for the treatment of otitis media with effusion in children 0 National Horizon Scanning Unit Horizon scanning prioritising summary Volume 11, Number 4: EarPopper ™ for the treatment of otitis media with effusion in children. December 2005 1 © Commonwealth of Australia 2005 This work is copyright. You may download, display, print and reproduce this material in unaltered form only (retaining this notice) for your personal, non-commercial use or use within your organisation. Apart from (...) Scanning Unit, Adelaide Health Technology Assessment, Department of Public Health, Mail Drop 511, University of Adelaide, South Australia, 5005 2 PRIORITISING SUMMARY REGISTER ID: 000178 NAME OF TECHNOLOGY: EARPOPPER ™ PURPOSE AND TARGET GROUP: TREATMENT OF OTITIS MEDIA WITH EFFUSION IN CHILDREN STAGE OF DEVELOPMENT (IN AUSTRALIA): ? Yet to emerge Established Experimental Established but changed indication or modification of technique Investigational Should be taken out of use Nearly established

2005 Australia and New Zealand Horizon Scanning Network

180. Antibiotic treatment for otitis media in children

Antibiotic treatment for otitis media in children Antibiotic treatment for otitis media in children Antibiotic treatment for otitis media in children Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation Antibiotic treatment for otitis media in children. Lansdale: HAYES, Inc.. Directory Publication. 2005 Authors' objectives Otitis media (OM) is a spectrum of diseases (...) MeSH Child; Otitis Media /drug therapy Language Published English Country of organisation United States English summary An English language summary is available. Address for correspondence HAYES, Inc., 157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218 Email: hayesinfo@hayesinc.com AccessionNumber 32006000084 Date bibliographic record published 02/02/2006 Date abstract record published 12/05/2010 Health Technology Assessment (HTA) database Copyright © 2019

2005 Health Technology Assessment (HTA) Database.